XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Net Income (loss) Per Share

 

 

For the Three Months Ended March 31,

(Unaudited)

 

 

 

2022

 

 

2021

 

Net Income (Loss)

 

$(659,484)

 

$(1,510,941)

Net income (loss) attributable to common shareholders

 

$(659,484)

 

$(1,510,941)

Weighted average number of shares of common stock outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

19,718,330

 

 

 

16,805,402

 

Diluted

 

 

19,718,330

 

 

 

16,805,402

 

Net income (loss) attributable to common shareholders per share:

 

 

 

 

 

 

 

 

Basic

 

$(0.03)

 

$(0.09)

Diluted

 

$(0.03)

 

$(0.09)

 

 

For the Three Months Ended March 31,

(Unaudited)

 

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

Net Income (Loss)

 

$(659,484)

 

$(1,510,941)

Denominator:

 

 

 

 

 

 

 

 

Basic weighted-average shares

 

 

19,718,330

 

 

 

16,805,402

 

Effect of dilutive securities

 

 

 

 

 

 

 

 

Warrants

 

 

-

 

 

 

-

 

Options

 

 

-

 

 

 

-

 

Preferred Stock

 

 

-

 

 

 

-

 

Diluted Weighted Average Shares

 

 

19,718,330

 

 

 

16,805,402

 

Net Income (Loss) Per Common Share:

 

 

 

 

 

 

 

 

Basic

 

$(0.03)

 

$(0.09)

Diluted

 

$(0.03)

 

$(0.09)
Disaggregation Of Revenue

 

 

For the three months ended March 31,

(Unaudited)

 

 

 

2022

 

 

2021

 

SteraMist Product

 

$1,886,000

 

 

$1,661,000

 

Service and Training

 

 

423,000

 

 

 

412,000

 

Total

 

$2,309,000

 

 

$2,073,000

 

 

 

For the three months ended March 31,

(Unaudited)

 

 

 

2022

 

 

2021

 

United States

 

$1,879,000

 

 

$1,804,000

 

International

 

 

430,000

 

 

 

269,000

 

Total

 

$2,309,000

 

 

$2,073,000